Fat,Frail and Dying Young: Survival,Body Weight and Pathology of the Charles River Sprague-Dawley-Derived Rat Prior to and Since the Introduction of the VAFR Variant in 1988

Abstract

Trends in survival and body weight were evaluated in 2140 control Sprague-Dawley-derived [Crl: COBS-CD(SD)BR and Crl: COBS-VAF CD(SD)BR] rats used for 24-month rat carcinogenicity studies between 1979 and 1991, Body weight and survival were remarkably stable in the CD-COBS rats used during 1979-1987: at 24 months, the mean survival in males was 68± 5%, and 60± 5% in females, With the CD-COBS-VAF rat, a variant of the CD-COBS strain used between 1988 and 1991, the survival at 24 months dropped to 41± 3% in males, and 44± 7% in females compared to the CD-COBS. The CD-COBS-VAF rat had a significantly reduced life span (P<0.001 at 24 months), a significant increase in mean body weight (males at 6 months : 672± 24 g vs. 536± 6 g; females : 359± 7 g vs 308± 3 g; P<0.001 ) and food consumption (males at 6 months : 31.3± 3.3 vs. 25.4± 2.1 g d^-1 ; females: 22,0± 2.7 g v. 20.3± 2.0 g d^-1 ; P<0.001). CD-COBS-VAF rats which failed to survive up to study termination had individual body weights at 3, 6 and 12 months which were significantly higher (P<0.001 ) than those which survived until 24 months. Our historical data base of control rats (CD-COBS and CD-COBS-VAF) in carcinogenicity studies revealed a significant (males:P<0.001; females:P<0.01) and inverse linear relation between mean 3-month body weight and 24-month survival. When compared to CD-COBS animals, CD-COBS-VAF rats showed an increase in the incidence of pituitary tumours in males, mammary fibroadenomas in females, an increase in the incidence and severity of glomerulonephrosis, and a greater incidence of animals which died without any obvious pathology. It is concluded that, in our Sprague-Dawley substrains, both the individual and the group mean body weights in early adult life appear predictive for the individual and group life expectancy. The decrease in longevity in the CD-COBS-VAF rat is principally due to disease and degeneration processes associated with fast growth and high body weight.

Get full access to this article

View all access options for this article.

References

Council recommendation concerning tests relating to the placing on the market of medicinal products, Annex III, carcinogenic potential (1983). The Council of the European Communities 83/571/EEC . In: The Rules Governing Medicinal Products in The European Community, Vol. III. Luxembourg : Offfice for Official Publications of the European Communities, 1989.

Office of Science and Technology Policy: chemical carcinogens: a review of the science and its associated principles . Federal Register, 1984; 49: and 1985; 50:

OECD Guidelines for Testing of Chemicals No 451. Carcinogenicity Studies. Paris: Organization for Economic Co-Operation and Development, Environment Directorate, 1981.

Lang PL Changes in life span of research animals leading to questions about validity of toxicologic studies. Chemical Regulation Reporter 1991; Jan 18: 1518-20.

Ministry of Health and Welfare, Japan. 1990 Guidelines for Toxicity Studies of Drugs Manual, New Drugs Division, Japan: Pharmaceutical Affairs Bureau, 1990. pp. 60-74.

Allaben WT The effects of caloric restrictions on spontaneous toxic end points and survivability in long-term rat studies. The Toxicology Forum, 1990. Transcript of the 1990 Annual Summer Meeting, Aspen, Colorado, USA 519-550.

Rao GN , Haeman JK , Grumbein S. , Crawford DD & Eustis S. Growth, body weight, survival and tumour trends in (C57BL/6xC3H/HeN)F1(B6C3F1) mice during a nine-year period. Toxicological Pathology 1991; 18: 71-7.

Rao GN , Haseman JK , Grumbein S. , Crawford D. , Eustis S. Growth, body weight, survival and tumour trends in F344/N rats during an eleven-year period, Toxicological Pathology 1990; 18: 61-70.

Emmerson J. Industry experience on survival of the Fischer 344 rat. The Toxicology Forum , 1990. Transcript of the 1990 Annual Summer Meeting, Aspen, Colorado , USA, pp. 506-18.

10.

Burek JD Survival experience with the Sprague-Dawley-derived rat. The Toxicology Forum , 1990. Transcript of the 1990 Annual Summer Meeting, Aspen, Colorado , USA 453-481.

11.

Szot RJ Rat survival: influences and experiences. The Toxicology Forum, 1990. Transcript of the 1990 Annual Summer Meeting , Aspen, Colorado, USA, pp. 437-44.

12.

Charles River France 'VAF - Le Standard International' St.-Aubin-les-Elbeut, France: Charles River France, 1989.

13.

US Department of Health and Human Services. Guidelines for the format and content of the non-clinical pharmacology/toxicology section of the application. Washington DC: Food and Drug Administration, Centre for Drugs and Biologics, 1987.

14.

Directive du Conseil due 24 Novembre 1986 concernant le rapprochement des dispositions legislatives, reglementaires et administratives des etats membres relatives a la protection des animaux utilises a des fins experimentales ou a d'autres fins scientifique. Journal Officiel des Communautes Europeennes 1986; L358: 1-28.

15.

Haseman JK , Huff JE , Rao GN & Eustis SL Sources of variability in rodent carcinogenicity studies. Fundamental and Applied Toxicology 1989; 12: 793-804.

16.

Haeman JK Use of statistical decision rules for evaluating laboratory animal carcinogencity studies. Fundamental and Applied Toxicology, 14: 637-48.

17.

Turnbull GJ , Lee PN & Roe Fjc. Relationship of body-weight gain to longevity and to risk of development of nephropathy and neoplasia in Sprague-Dawley rats. Food and Chemical Toxicology 1985; 23: 355-61

18.

Roe Fjc. Letter to the editor. Fundamental and Applied Toxicology 1991; 16: 616-18.

19.

Roe FC , Lee G. Conybeare G. et al. Risk of premature death and cancer predicted by body weight in early life, Human and Experimental Toxicology 1991; 10: 285-8.

20.

Ross MH Dietary behaviour and longevity, Nutrition Reviews 1977; 35: 257-65.

21.

Squire AR , Goodman DG & Valeiro MG Tumours. In: Pathology of Laboratory Animals, Benirschke K , Garner FM , Jones TC , ed, Vol II, chapter 12, p. 1228. New York: Springer Verlag, 1978.

22.

Anver MR & Cohen BJ Lesions associated with aging. In: The Laboratory Rat, Vol I, Biology and Diseases, chapter 14, p. 378. New York: Academic Press, 1979.

23.

Owen RA & Heywood R.

Age-related variations in renal structure and function in Sprague-Dawley rats. Toxicological

Pathology 1986; 14: 158-67.

24.

Masoro EJ & Yu BP Diet and nephropathy. Laboratory Investigation 1989; 60: 165-7.

25.

Bertani T. , Zoja C. , Abbate M. , Rossini M. , & Remuzzi G. Age-related nephropathy and proteinurea in rats with intact kidneys exposed to diets with different protein content. Laboratory Investigation 1989; 60: 196-204.

26.

Tapp DC , Wortham WG , Addison JF et al. Food restriction retards body growth and retards end-stage renal pathology in remnant kidneys of rats regardless of protein intake. Laboratory Investigation 1989; 60: 184-95.

27.

White WJ Issues in Toxicology: Animal Quality, Consistency, Longevity, Fertility and Age/Weight Correlations, Transcript of the 3rd Short Course on Laboratory Animals, Charles River, April 15 and 16. Paris, France, 1991.

28.

Nolen GA

Effects of various restricted dietary regimes on the growth, health and longevity of albino rats. Journal of

Nutrition, 1972 ; 102: 1477-93.

29.

Rao GN , Haseman JK & Edmondson. Influence of viral infections on body weight, survival, and tumour prevalence in Fischer 344/NCr rats on two-year studies. Laboratory Animal Science 1989; 39: 389-93.

30.

Ross MH , Lustbader ED & Bras G. Dietary practices in early life and spontaneous tumours of the rat. Nutrition and Cancer 1982; 3: 150-67.

31.

Roe Fjc.

Are nutritionists worried about the epidemic of tumours in laboratory animals? Proceedings

Nutrition Society 1981; 40: 57-65.

32.

Weissinger J. Current and future regulatory policy on carcinogenicity testing - FDA policy. Drug Information Association Meeting 'Carcinogenicity Testing: A Contentious Area in the Non-Clinical Safety Assessment of Medicinal Products', Montreux, Switzerland, September 16-19, 1991.

33.

Bass R. Current and future regulatory policy on carcinogenicity testing - EC Policy . Drug Information Association Symposium: Carcinogenicity Testing: A Contentious Area in the Non-Clinical Safety Assessment of Medicinal Products, Montreux, Switzerland, September 16-19, 1991.

34.

Haseman JK , Huff JE , Rao GN et al. Neoplasms observed in untreated and corn oil gavage control groups of F344/N rats and (C57 BL/6N x CH3/HcN)F1 (B6C3F1) mice. Journal of the National Cancer Institute 1985; 75: 975-84.

35.

Tucker MJ Factors influencing carcinogenicity testing in rodents. Human Toxicology 1987; 6: 107-9.

36.

Ross MH , Bras G.

Influence of protein under- and overnutrition on spontaneous tumour prevalence in the rat. Journal of

Nutrition 1973; 103: 944-63.